Image

Neural Enabled Prosthesis for Upper Limb Amputees

Neural Enabled Prosthesis for Upper Limb Amputees

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This study is designed to evaluate the feasibility of The Adaptive Neural Systems Neural-Enabled Prosthetic Hand (ANS-NEPH) system.

Description

The purpose of this study is to evaluate a new prosthetic system for transradial amputees called the neural-enabled prosthetic hand (ANS-NEPH). It is intended to provide the sense of touch, grasp force and hand opening to the user by sending electrical stimulation pulses to electrodes implanted in nerve fascicles in the upper arm of the residual limb. The system uses measurements from sensors in the prosthetic hand and wireless communication to the implanted neurostimulator to adjust the pulses continuously so that the user gets sensation as tasks are performed with the prosthesis.

Eligibility

Inclusion Criteria:

  1. Unilateral transradial amputation
  2. Amputation occurred 9 months ago or more
  3. Functional hand contralateral to the amputation
  4. Ability and willingness to use myoelectric arm (as determined by prosthetist)
  5. 18 years of age or older
  6. Ability to obtain transportation to the research site and the clinicians' offices
  7. U.S. citizen or permanent U.S. resident
  8. Signed the Informed Consent Form

Exclusion Criteria:

  1. Absence of limb due to birth defect
  2. Evidence of denervation of the residual limb
  3. Phantom limb pain that is severe enough to impair or restrict activity
  4. Any neurological condition affecting motor and/or sensory function that would interfere with use of the intact hand or residual limb (as determined by neurologist)
  5. Visual impairment that would affect hand usage during experimental procedures
  6. History of chronic infections
  7. History of recurring ulcers or blisters on the residual limb
  8. Evidence of an active infection, non-healed ulcer, recent history of a healed ulcer (< 3 months)
  9. Use of another implanted electrical device (such as a pacemaker or nerve stimulator)
  10. Undergoing diathermy therapy of the residual limb
  11. History of non-compliance with medical or research procedures or any condition that would limit their ability to comply with study related procedures (self-reported)
  12. Self-reported emotional or psychological disorders or history of drug or alcohol abuse or addiction
  13. Memory disorders or significant cognitive impairment (self-reported and/or clinical observation during consent and screening procedures)
  14. Moderate to severe chronic pain
  15. Pregnant or nursing
  16. Self-reported sensitivity to material derived from porcine source
  17. Enrolled in another investigational research study
  18. Any medical or psychiatric condition not otherwise specified (such as uncontrolled high blood pressure, heart or lung disease, active infection, and serious metabolic disorders) that would expose the subject to unacceptable risk and/or limit their ability to perceive meaningful sensation from stimulation of the peripheral nerves of the residual limb.

Study details
    Amputation Arm and Hand
    Unilateral Right
    Amputation Arm and Hand
    Unilateral Left
    Prosthesis User

NCT03432325

University of Arkansas, Fayetteville

27 May 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.